The epigenetic mechanisms involved in mitochondrial dysfunction: Implication for Parkinson's disease

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Mitochondrial dysfunction is a key factor in Parkinson's disease (PD) pathogenicity, stemming from genetic and environmental influences.
• These factors lead to molecular changes in neurons, including oxidative stress, alpha-synuclein aggregation, and neurotoxin release, impacting dopaminergic neurons (DN).
• The complex interplay between these factors and mitochondrial anomalies in PD remains poorly understood, complicating diagnosis and treatment.

Purpose of the Study:

• To review the intricate relationship between epigenetic modifications and mitochondrial dysfunction in PD.
• To propose a hypothesis detailing a vicious cycle contributing to dopaminergic neuron degeneration in PD.
• To identify potential diagnostic biomarkers and therapeutic targets for novel PD management strategies.

Main Methods:

• Literature review focusing on epigenetic modifications, oxidative stress, and mitochondrial dysfunction in PD.
• Analysis of molecular mechanisms underlying dopaminergic neuron damage in Parkinson's disease.
• Hypothesis formulation based on the proposed vicious cycle model.

Main Results:

• A vicious cycle model is proposed where mitochondrial dysfunction, oxidative stress, and epigenetic modifications exacerbate each other.
• This cycle involves the release of endogenous neurotoxins (CTIQs), abnormal alpha-synuclein aggregation, and damage to dopaminergic neurons.
• Both neurotoxic and neuroprotective endogenous compounds and epigenetic marks are identified.

Conclusions:

• The proposed vicious cycle offers a framework for understanding PD pathogenesis and dopaminergic neuron degeneration.
• Epigenetic modifications and mitochondrial dysfunction are central to PD progression.
• Identified factors may serve as future diagnostic biomarkers and targets for novel therapeutic interventions in Parkinson's disease.